Scribe Therapeutics, Inc.

SCTX · XNAS

CIK 1853921fmd_1Y04QGHWC0KYBEWS3H5WZF8KQEManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2025 to Sep 30, 2026, 6 periods